Puma Biotechnology, Inc. (PBYI)
6.415
+0.72
(+12.54%)
USD |
NASDAQ |
Mar 02, 16:00
6.45
+0.04
(+0.55%)
After-Hours: 20:00
Puma Biotechnology EPS Diluted (Quarterly) : 0.2608 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.612 |
| Pfizer Inc. | -0.2898 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| CorMedix, Inc. | 1.259 |
| BioXcel Therapeutics, Inc. | -2.177 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 13.44M |
| Revenue (Quarterly) | 75.45M |
| Total Expenses (Quarterly) | 62.02M |
| Enterprise Value | 216.16M |
| Gross Profit Margin (Quarterly) | 69.35% |
| Profit Margin (Quarterly) | 17.81% |
| Earnings Yield | 9.52% |
| Operating Earnings Yield | 11.48% |
| Normalized Earnings Yield | 9.521 |